AnalystsGavin Clark-GartnerGavin Clark-Gartner's Stock Forecasts
AnalystsGavin Clark-Gartner
Analyst Ranking
Bottom 11%
#4940 out of 5523 analysts
Average Return
-1.84%
Win Rate
41%23 out of 56
Risk vs Reward
Poor
Good
Gavin Clark-Gartner's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Forte Biosciences IncFBRX | +285.14% | $19.99 | $76.99 | 2025-11-25 - 2026-08-27 | Buy |
Definium Therapeutics IncDFTX | +135.26% | $7.43 | $17.48 | 2025-01-28 - 2026-01-27 | Buy |
Argenx SeARGX | +76.16% | $354.13 | $623.82 | 2023-12-21 - 2024-12-20 | Buy |
Mirum Pharmaceuticals IncMIRM | +67.83% | $59.97 | $100.65 | 2025-08-08 - 2026-08-07 | Buy |
Argenx SeARGX | +53.92% | $596.74 | $918.50 | 2024-11-21 - 2025-11-20 | Buy |
Gavin Clark-Gartner Analyst Color
Get additional color on Gavin Clark-Gartner's coverage of popular stocks
Gavin Clark-Gartner's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
First Tracks Biotherapeutics IncTRAX | 1 | Buy | $65.00 | +77.38% | Initiates Coverage On | 12 days ago |
Tenax Therapeutics IncTENX | 2 | Hold | $5.00 | +170.27% | Downgrades | 2 months ago |
Abbvie IncABBV | 9 | Buy | $260.00 | -2.36% | Maintains | 2 months ago |
Dianthus Therapeutics IncDNTH | 1 | Buy | $134.00 | +52.57% | Maintains | 2 months ago |
Compass Pathways PLCCMPS | 1 | Buy | $21.00 | +58.73% | Upgrades | 3 months ago |
Crinetics Pharmaceuticals IncCRNX | 1 | Hold | $85.00 | +0.06% | Downgrades | 3 months ago |
Proqr Therapeutics NvPRQR | 2 | Buy | $6.00 | +263.64% | Maintains | 3 months ago |
C4 Therapeutics IncCCCC | 2 | Buy | $12.00 | +285.23% | Maintains | 4 months ago |
Avalyn Pharma IncAVLN | 1 | Buy | $51.00 | +80.08% | Initiates Coverage On | 4 months ago |
Vera Therapeutics IncVERA | 2 | Buy | $91.00 | +180.00% | Maintains | 4 months ago |
Dyne Therapeutics IncDYN | 2 | Buy | $33.00 | +101.96% | Maintains | 4 months ago |
Argenx SeARGX | 6 | Buy | $1,059.00 | +8.92% | Maintains | 4 months ago |
Mirum Pharmaceuticals IncMIRM | 6 | Buy | $138.00 | +56.89% | Maintains | 5 months ago |
Krystal Biotech IncKRYS | 2 | Buy | $300.00 | -11.00% | Maintains | 5 months ago |
Meiragtx Holdings PLCMGTX | 1 | Buy | $18.00 | +62.02% | Maintains | 6 months ago |
Jasper Therapeutics IncJSPR | 5 | Buy | $7.00 | +1,018.21% | Maintains | 6 months ago |
Damora Therapeutics IncDMRA | 1 | Buy | $46.00 | +121.69% | Initiates Coverage On | 6 months ago |
Evommune IncEVMN | 1 | Buy | $40.00 | +376.76% | Initiates Coverage On | 10 months ago |
Forte Biosciences IncFBRX | 1 | Buy | $65.00 | -15.57% | Initiates Coverage On | 10 months ago |
Definium Therapeutics IncDFTX | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 2 years ago |
Cabaletta Bio IncCABA | 2 | Hold | $6.00 | N/A | Downgrades | 2 years ago |
Sarepta Therapeutics IncSRPT | 9 | Buy | $170.00 | N/A | Maintains | 2 years ago |
Foghorn Therapeutics IncFHTX | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Inhibrx IncINBX1 | 1 | Buy | $60.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.